Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
July 2015—The patented PrestoChill is an all-dry cryoembedding system from Milestone Medical that does not use liquid nitrogen, CO2, or isopentane. The 60-second freezing time prevents the formation of ice crystals. An automatic defrost cycle is provided to eliminate the potential formation of ice on the freezing platform.
July 2015—Eppendorf has added two screw-cap tubes in 15 mL and 50 mL sizes to its line of Eppendorf Tubes. The newly designed screw caps provide optimal sealing properties, and their grooved and multisurface side contour provide a secure, slip-free grip.
July 2015—Enzo’s TIMP-1 ELISA kit is designed to provide a useful tool for investigating the TIMP-1 levels in multiple human matrices and aims to advance the studies on TIMP-1 function. The assay format allows for quantitative detection of 30 pg/mL of TIMP-1 in various sample types including serum, plasma, saliva, urine, and tissue culture media.
July 2015—Euroimmun US announced the FDA 510(k) clearance of its EuroPattern System, which consists of a fluorescent microscope (oculars included for manual interpretation) and software that acquires, interprets, archives, and displays digital images of stained IFA slides.
July 2015—Biocartis presented liquid biopsy data from the company’s BRAF mutation study at the American Society of Clinical Oncology annual meeting in June. The study, in collaboration with Bart Neyns, MD, PhD, University Hospital Brussels, showed that BRAF oncogene mutations monitored in plasma from metastatic melanoma patients on Biocartis’ Idylla system were significantly associated with treatment response and progression.
June 2015—Horizon Discovery Group and ArcherDX have signed an original equipment manufacturer agreement in which Horizon’s reference materials will be supplied as a standalone product alongside ArcherDX’s Archer FusionPlex to aid customer validation of its ALK fusion assay kits. The ALK fusion tests can run on both Illumina and Ion Torrent next-generation sequencing platforms.
June 2015—Rosetta Genomics has agreed to acquire CynoGen, which does business as PersonalizeDx, from Prelude Corp., a Fjord Ventures portfolio company. The acquisition is contingent upon the closing of Prelude’s purchase of PersonalizeDx from a third party.
June 2015—Beckman Coulter Diagnostics will distribute four new immunosuppressant drug user defined reagents as part of the company’s therapeutic drugs monitoring menu on its AU family of clinical chemistry systems.
June 2015—Microbiologics has entered into an agreement to source inactivated viruses from Microbix Biosystems. Microbiologics will incorporate these inactivated materials into a line of full process controls under its Helix Elite Molecular Standards brand as well as instrument-specific quality control sets.
June 2015—Thermo Fisher Scientific announced the release of the CE-IVD Oncomine Solid Tumour Fusion Transcript kit designed to aid clinical decision-making and enable highly accurate and reliable multiplexed sequencing of formalin-fixed, paraffin-embedded tumor samples.
